Cytokinetics (CYTK) Announces Offering of Common Stock, Warrants and Series B Convertible Preferred Shares
Tweet Send to a FriendGet Alerts CYTK Hot Sheet
Up)
Trade CYTK Now!
Cytokinetics (Nasdaq: CYTK) announces a public offering of common stock, Series B Convertible Preferred shares, and corresponding warrants.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Apricus Bio (APRI) Prices 6M Common Stock Offering
- Bloomin' Brands (BLMN) Prices 19M Common Stock Secondary Offering
- Yingli Green Energy (YGE) to Supply 10.269 MW Modules to Malaysia Power Plant
Create E-mail Alert Related Categories
Corporate News, Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
